FDA Inspection 1307194 — Give Legacy - New Jersey, LLC

Give Legacy - New Jersey, LLC — FEI 3024743004

The FDA completed an inspection of Give Legacy - New Jersey, LLC on Mar 10, 2026 in Hoboken, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 10, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Hoboken, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.